The development of recombinant cytokine technology has yielded valuable signatures for key immune signaling molecules: IL-1A, IL-1B, IL-2, and IL-3. These engineered forms, meticulously created in laboratory settings, offer advantages like enhanced purity and controlled functionality, allowing researchers to analyze their individual and combined ef